A new preclinical study reveals that KRAS-mutant gastric adenocarcinoma fosters a TGF-beta-dependent immunosuppressive tumour ...
Lead ADC candidate BYON14156 harnesses company’s first-in-class antifolate payload platform to overcome major payload resistance challenge seen ...
KymaThera plans to dose the first patients in its Phase I trial on K-1728 in Q4 2026.
Heart and kidney complications remain a major concern for people living with type 1 diabetes (T1D). While there are some therapies available to reduce the risk of these complications, the T1D ...
When you look at the internet or social media, don't you ever feel that your thinking is becoming biased because you are ...
Standardized patient-derived glioblastoma organoids mirrored patients' radiotherapy responses and showed BET inhibitors may overcome radiation resistance.
Forward Therapeutics, Inc. (“Forward” or the “Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced positive ...
A new review in Acta Neuropathologica chronicles how Byron Caughey's development of the RT-QuIC assay revolutionized prion ...
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company addressing drug resistance in cancer, today announced positive interim efficacy data from its ongoing Phase 2 ...
Identify high-potential STAT assets through clinical and commercial benchmarking, unmet-need analysis, and tracking collaborations, licensing, M&A and novel technologies.Dublin, Oct. 01, 2026 (GLOBE ...
That sliminess of mozuku vinegarYou know, mozuku vinegar.The kind sold in three-packs at the supermarket. I often buy it in ...
In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who found that eating an apple helps their heartburn.